The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An anti-EpCAM x anti-CD3 bispecific antibody, M701, for the treatment of malignant ascites due to epithelial cancer: Interim results of a prospective randomized controlled phase II trial.
 
Rongbo Lin
No Relationships to Disclose
 
Jianming Xu
No Relationships to Disclose
 
Rongrui Liu
No Relationships to Disclose
 
Ning Li
No Relationships to Disclose
 
Guiling Li
No Relationships to Disclose
 
Tao Zhang
No Relationships to Disclose
 
Jun Zhao
No Relationships to Disclose
 
Jiayi Li
No Relationships to Disclose
 
Meili Sun
No Relationships to Disclose
 
Ke Wang
No Relationships to Disclose
 
Hanxiang An
No Relationships to Disclose
 
Weijie Zhang
No Relationships to Disclose
 
Huiting Xu
No Relationships to Disclose
 
Shan Zeng
No Relationships to Disclose
 
Mingjun Zhang
No Relationships to Disclose
 
Pengfei Zhou
Employment - Wuhan YZY Biopharma Co., Ltd.
Stock and Other Ownership Interests - Wuhan YZY Biopharma Co., Ltd.
Patents, Royalties, Other Intellectual Property - Wuhan YZY Biopharma Co., Ltd.
 
Shaoyi Huang
Employment - Wuhan YZY Biopharma Co., Ltd.
Stock and Other Ownership Interests - Wuhan YZY Biopharma Co., Ltd
 
Xiong Wang
Employment - Wuhan YZY Biopharma Co., Ltd.
Stock and Other Ownership Interests - Wuhan YZY Biopharma Co., Ltd.